Partner with Effectus to support a nearby clinical trial for patients with advanced or metastatic solid tumor malignancies or lymphoma.

Provide your contact information below and a member of the Effectus team will reach out with program details. Should you have any questions prior, please call us directly at 973-753-2430.

About the Clinical Trial

Moderna’s Phase 1 dose escalation research trial is evaluating the safety and tolerability of mRNA-2752 administered alone and in combination with durvalumab for patients with advanced or metastatic solid tumor malignancies or lymphoma.

How You Can Get Involved

As a health care provider (HCP) who sees adult patients with advanced or metastatic solid tumor malignancies or lymphoma, you are invited to participate in the Effectus Patient Identification and Consultation Program to help identify candidates for the Moderna mRNA-2752-P101 trial. You will be asked to consult with patients in a neutral manner about the trial and assess their interest in participating at a nearby trial site. Patients may be able to take part if they are 18 years of age or older and meet additional high-level criteria (key trial criteria will be provided to you upon onboarding). At the trial site, patients will undergo trial screening to determine eligibility.

Compensation at fair market value will be available for HCPs who participate and meet program requirements.

Support Provided

Effectus will be your trusted partner throughout your participation, helping to facilitate your patients to the trial site and thus relieving the burden on your practice. If you wish to participate, you will be asked to review and sign a Services Agreement with Effectus, which outlines your program responsibilities and compensation. Participation is completely voluntary, and you can opt out at any time. Background on the trial, program materials, and program logistics will be reviewed in detail during a 1-hour virtual training session.

Why You Should Participate

The Moderna mRNA-2752-P101 trial provides an opportunity to contribute to the research and advancement of a potential new treatment option for patients with advanced or metastatic solid tumor malignancies or lymphoma. The trial also allows HCPs the opportunity to offer alternative treatment options to their patients.

The Effectus Patient Identification and Consultation Program

    Thank you for expressing preliminary interest in partnering with Effectus to support an oncology trial being conducted near you. Please provide your contact information below and a member of the Effectus team will reach out with more information. Should you have any questions prior, please call us at 973-753-2430.

    *Please provide the following information:

    Name:
    Specialty:
    Email Address:
    Phone Number:

    By opting-in and completing this Consent Form, you consent to your personal information being processed by or on behalf of Effectus for the purposes set forth herein.

    Your Personal Information:

    • We collect and process your personal information to (1) notify you about program opportunities, and (2) pay your compensation should you participate in a program.
    • If you are located outside the US, your personal information may be transferred to the US and disclosed to our US service providers.
    • We will retain your personal information only for the time necessary to accomplish the purposes stated herein and to comply with applicable laws.
    • We will not share or sell your personal information outside of Effectus.

    Healthcare providers who reside in the state of Vermont are ineligible for participation. 

    89 Headquarters Plaza North, Suite #1450, Morristown, NJ 07960

    Effectus Patient Identification and Consultation Program Overview

    Sign a services
    agreement.

    Receive a package of
    program materials and
    complete a simple, one-hour
    virtual training session.

    Utilize key screening
    criteria to identify
    potentially eligible
    patients.

    If the patient meets the criteria,
    conduct a neutral consultation
    about the availability of the
    nearby trial and gauge the
    patient’s interest.

    If the patient is interested in
    participation, our team of dedicated
    Patient Facilitators help ensure a
    smooth patient transfer from your
    office to the clinical trial site.

    The patient is scheduled
    and presents at the trial
    site for the screening
    appointment.

    The patient’s enrollment
    status is determined and is
    relayed back to the treating
    HCP by Effectus.

    For more information on our program, please visit https://www.effectusctr.com/physician-network/.

    Contact Us

    Montana Markell, Project Coordinator

    Phone: 973-753-2430

    Email: mmarkell@effectusctr.com

    How can you get involved? It’s easy!

    Want to learn about available programs near you? Contact Effectus today to become part of our growing network of health care providers, allowing you to participate in programs and learn about the latest developments in clinical research.

    Join the Effectus Network

    …or contact us for more information.

      Please prove you are human by selecting the Truck.

      Effectus Clinical Trial Recruitment
      89 Headquarters Plaza
      Suite #1450
      Morristown, NJ 07960

      Scroll to top

      This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

      I AgreeLearn More×

      Cookie and Privacy Settings



      How we use cookies

      We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

      Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

      Essential Website Cookies

      These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

      Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.

      Google Analytics Cookies

      These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

      If you do not want that we track your visist to our site you can disable tracking in your browser here:

      Privacy Policy

      You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

      Privacy Policy
      5
      Accept settingsHide notification only